Immune Design's IPO

Immune Design raised a round of funding on July 24, 2014. Investors include Public.

Immune Design is a clinical-stage biotechnology company developing two synergistic platforms of next-generation vaccines designed to treat cancer, infectious diseases, allergy, and autoimmune disorder…

Articles about Immune Design's IPO: